QuidelOrtho (QDEL) Long-Term Investments (2022 - 2023)
QuidelOrtho (QDEL) reported Long-Term Investments of $7.4 million for Q4 2023, down 64.76% on a YoY basis from $21.0 million in Q4 2022, and down 37.82% sequentially from $11.9 million in Q4 2023.
QuidelOrtho (QDEL) Long-Term Investments (2022 - 2023) Analysis & Trends
QuidelOrtho (QDEL) has 2 years of Long-Term Investments data on file, last reported at $7.4 million in Q4 2023.
- For the quarter ending Q4 2023, Long-Term Investments fell 64.76% year-over-year to $7.4 million; the trailing twelve-month figure through Dec 2023 stood at $7.4 million (down 64.76% YoY), and the FY2023 full-year result was $7.4 million, down 64.76% from the prior year.
- Long-Term Investments retreated to $7.4 million in Q4 2023, from $11.9 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $37.9 million in Q1 2022 to a low of $7.4 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | QuidelOrtho | 1.13 Bn | 990.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7.40 Mn |
| Oct 1, 2023 | 11.90 Mn |
| Jul 2, 2023 | 24.70 Mn |
| Apr 2, 2023 | 33.80 Mn |
| Jan 1, 2023 | 21.00 Mn |
| Oct 2, 2022 | 20.30 Mn |
| Jul 3, 2022 | 15.20 Mn |
| Jan 2, 2022 | 37.90 Mn |